Erenumab for Idiosyncratic Facial Pain

Status Completed

Clinical Trial Summary

This is a phase IV randomized, double-blinded, placebo-controlled study to evaluate the efficacy of Erenumab in subjects with midfacial pain or pressure, without clinical or radiographic evidence of sinusitis.

Clinical Trial Description

Eligible participants are randomized to receive either Erenumab or placebo by subcutaneous injection once monthly for 6 months. Study duration is eight months which includes a 30 day screening/lead-in period and 6 monthly treatment visits followed by a follow-up visit one month following the last dose of study drug administration. Participants will be expected to score on a scale of 1 to 10 their symptoms of facial pain/pressure, nasal congestion, and rhinorrhea as well well as any rescue medicines taken for pain each day via a mobile app. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04249427
Study type	Interventional
Source	Duke University
Contact
Status	Completed
Phase	Phase 4
Start date	February 10, 2021
Completion date	July 11, 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02636790` - Early Versus Late Surgical Wait Times	Early Phase 1
Completed	`NCT02712502` - Levofloxacin in Bacterial Rhinosinussitis	N/A
Completed	`NCT00986830` - Healthcare Utilization and Outcomes of FinESS Treatment in the Office	N/A
Completed	`NCT00534079` - Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis	Phase 3
Completed	`NCT05442606` - Physiotherapy Protocol in Treating Chronic Rhinosinusitis	N/A
Completed	`NCT01955980` - Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis	Phase 1/Phase 2
Completed	`NCT04123405` - Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis	Phase 3
Completed	`NCT00797004` - Olfactory Dysfunction of Rhinosinusitis	N/A
Recruiting	`NCT05494346` - Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction	N/A
Not yet recruiting	`NCT05836935` - Role of Imaging in Complications of Sinusitis	N/A
Withdrawn	`NCT02097576` - Manuka Honey Nasal Rinse Study	N/A
Completed	`NCT01132781` - Theophylline in Rhinitis	Phase 2
Recruiting	`NCT00948519` - Laser Assisted Treatment of Chronic Sinusitis With and Without Light Activated Agents	N/A
Completed	`NCT00554190` - Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel	Phase 4
Recruiting	`NCT03729258` - Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.	Phase 3
Withdrawn	`NCT03729310` - Comparison of Two Steroid Nasal Implants Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis	Early Phase 1
Recruiting	`NCT01296919` - The Clinical Significance of the Uncinate Process Histopathology in Chronic Rhinosinusitis	N/A
Completed	`NCT01086839` - Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis	N/A
Completed	`NCT00849953` - FinESS Registry Study	N/A
Withdrawn	`NCT00669799` - Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled Study	N/A